Get the Daily Brief

All action, no filler. BioBriefs delivers biotech’s 10 must-know updates, every morning.

Latest Biotech News

Environmental and Climate Science Unveil Emerging Risks and Mechanisms

July 06, 2025

Cutting-edge environmental research details intense climate change impacts and human vulnerability. Studies demonstrate early detectable climate fingerprints using extensive simulations,...

Plant Biology Deciphers Environmental Signal Integration and Defense

July 06, 2025

Advances in plant molecular biology elucidate mechanisms of environmental responsiveness and defense. Research demonstrates how temperature elevations boost FKF1 protein to trigger flowering,...

Clinical and Therapeutic Advances in Liver and Bladder Cancer

July 06, 2025

Significant progress has been made in targeting liver and bladder malignancies. Identification of S100A4’s role in driving hepatocellular carcinoma metastasis via interaction with NMIIA elucidates...

CRISPR Erases Extra Chromosome in Down Syndrome Cells

July 05, 2025

Japanese researchers at Mie University have successfully used CRISPR-Cas9 gene editing to remove the extra chromosome 21 responsible for Down syndrome in cultured human stem and skin cells. This...

FDA Removes REMS from CAR-T Therapies to Enhance Access

July 05, 2025

The FDA has eliminated Risk Evaluation and Mitigation Strategies (REMS) from six approved CAR-T cell therapies targeting BCMA and CD19 antigens used in multiple myeloma and certain leukemias and...

New Noninvasive Gene Methylation Test Detects Nasopharyngeal Cancer Early

July 05, 2025

Researchers developed a novel, noninvasive diagnostic technique utilizing DNA methylation biomarkers obtained from bilateral nasal swabs processed automatically to detect nasopharyngeal carcinoma....

Metabolic Reprogramming Drives Immune Evasion in Melanoma Therapy

July 05, 2025

New insights into melanoma tumor metabolism reveal metabolic reprogramming as a significant barrier to effective immunotherapy. Complex interactions within the tumor microenvironment inhibit...

Gene Editing Advances Target Aggressive Bladder Cancer Pathways

July 05, 2025

Researchers uncovered the role of transcription factor TCF3 in bladder cancer progression via modulation of the TMBIM6-Ca²⁺ ferroptosis pathway. This novel mechanism offers potential therapeutic...

AI-Powered Framework Deciphers Gut Microbiome and Metabolite Interactions

July 05, 2025

A team from the University of Tokyo introduced VBayesMM, an advanced artificial intelligence platform employing variational Bayesian neural networks, to analyze complex relationships between human...

Long-Acting Injectable Combo Shows Promise for HIV Treatment in Africa

July 05, 2025

A recent study published in Nature Communications evaluated the efficacy and cost-effectiveness of combining long-acting injectable antiretrovirals lenacapavir and cabotegravir for HIV treatment...

Novel Plasma Method Converts Air into Ammonia for Sustainable Production

July 05, 2025

Researchers at the University of Sydney developed an innovative plasma-driven technique to synthesize ammonia directly from atmospheric nitrogen, bypassing traditional energy-intensive Haber-Bosch...

Synthetic Gait Data Enhances Musculoskeletal Healthcare Applications

July 05, 2025

A 2025 Nature Communications study presents the utility of synthetic musculoskeletal gait data generated through AI for clinical and research purposes. By simulating diverse gait patterns, this...

New Chemical Staples Stabilize Collagen Integrity at Body Temperature

July 05, 2025

Researchers at Simon Fraser University identified cysteine residues serving as chemical 'staples' critical for the stability of type IV collagen at physiological temperatures despite its inherent...

FDA Removes Safety Restrictions on CAR T Therapies – Boosting Community Access

July 05, 2025

The FDA has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for six CAR T cell therapies targeting BCMA and CD19 antigens, including products by Bristol Myers Squibb, Johnson &...

CRISPR Deletes Extra Chromosome to Reverse Down Syndrome in Cells

July 05, 2025

Japanese researchers at Mie University achieved a pioneering feat by using CRISPR-Cas9 to selectively remove the extra chromosome 21 responsible for Down syndrome in cultured human cells. This...

New AI Model Enhances Pathologist Accuracy in Skin Cancer Diagnoses

July 05, 2025

A collaborative study led by Karolinska Institutet and Yale University demonstrates that artificial intelligence significantly improves pathologists’ accuracy and consistency in assessing...

Innovative Plasma Method Enables Sustainable Ammonia Production

July 05, 2025

Scientists at the University of Sydney have developed a plasma-driven process to produce ammonia directly from air, offering a carbon-neutral alternative to the conventional Haber-Bosch method....

Novel Liquid Biopsy Biomarkers Predict Peritoneal Spread in Gastric Cancer

July 05, 2025

Researchers have identified plasma microRNAs miR-9 and miR-106a as significant indicators associated with peritoneal carcinomatosis in gastric cancer patients. This non-invasive biomarker panel,...

Synthetic DNA Nanoparticles Open New Frontiers in Gene Therapy

July 05, 2025

Dr. Divita Mathur at Case Western Reserve University secured an NSF CAREER grant to develop synthetic DNA nanoparticles with enhanced cellular uptake and intracellular dynamics. This innovative...

FDA Approval Positions Dizal’s Lung Cancer Drug Against J&J’s Rybrevant

July 05, 2025

Dizal Pharmaceutical received FDA approval for Zegfrovy, a treatment targeting a rare genetic subtype of non-small cell lung cancer. Positioned as a competitor to Johnson & Johnson’s Rybrevant,...